uniQure
QURE
#3999
Rank
A$4.72 B
Marketcap
A$68.77
Share price
-0.25%
Change (1 day)
224.50%
Change (1 year)

uniQure (QURE) - Total debt

Total debt on the balance sheet as of March 2026 : A$91.88 Million

According to uniQure's latest financial reports the company's total debt is A$91.88 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

uniQure - Total debt on balance sheet (from 2012 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$94.64 M-10.89%
2024-12-31A$0.10 B-47.72%
2023-12-31A$0.20 B-3.25%
2022-12-31A$0.20 B12.16%
2021-12-31A$0.18 B101.21%
2020-12-31A$93.04 M-10.84%
2019-12-31A$0.10 B107.25%
2018-12-31A$50.35 M89.07%
2017-12-31A$26.63 M-5.14%
2016-12-31A$28.07 M1.19%
2015-12-31A$27.74 M8.34%
2014-12-31A$25.6 M122.21%
2013-12-31A$11.52 M1912.3%
2012-12-31A$0.57 M151.69%
2011-12-31A$0.22 M-21.37%
2010-12-31A$0.28 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
A$83.18 B 90,426.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$33.62 B 36,495.02%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
A$36.89 M-59.85%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
A$0.27 B 197.12%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.08 B 2,173.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
A$71.46 M-22.22%๐Ÿ‡บ๐Ÿ‡ธ USA